Aker BioMarine ASA (OSL:AKBM)

Aker BioMarine ASA Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 1, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	9,384	8,656	5,884	4,033	3,335	4,756
Market Cap Growth	84.80%	47.13%	45.89%	20.94%	-29.89%	-53.79%
Enterprise Value	11,051	10,398	7,308	8,170	7,246	7,421
Last Close Price	107.00	98.70	67.10	25.59	21.16	30.20
PE Ratio	-	-	2.84	-	33.85	-
Forward PE	40.51	39.34	179.33	80.58	30.13	-
PS Ratio	4.27	3.94	2.60	2.03	1.22	2.06
PB Ratio	6.47	5.97	3.10	1.09	0.89	1.46
P/TBV Ratio	20.64	19.04	8.91	1.85	1.54	2.68
P/FCF Ratio	-	-	-	265.14	-	-
P/OCF Ratio	221.65	204.45	42.45	8.39	22.42	207.63
EV/Sales Ratio	5.03	4.73	3.23	4.10	2.65	3.21
EV/EBITDA Ratio	32.92	30.07	17.34	77.47	12.04	21.88
EV/EBIT Ratio	105.41	80.59	-	-	45.12	-
EV/FCF Ratio	-522.01	-	-	537.11	-	-
Debt / Equity Ratio	1.27	1.27	0.88	1.07	1.01	0.88
Debt / EBITDA Ratio	5.10	5.10	3.80	31.95	5.82	7.37
Debt / FCF Ratio	-	-	-	262.00	-	-
Net Debt / Equity Ratio	1.15	1.15	0.79	1.00	0.95	0.85
Net Debt / EBITDA Ratio	4.82	4.82	3.57	35.14	5.87	8.15
Net Debt / FCF Ratio	-78.71	-78.71	-25.48	243.67	-14.13	-4.12
Asset Turnover	0.57	0.57	0.33	0.24	0.35	0.36
Inventory Turnover	1.22	1.22	0.88	0.65	0.97	1.38
Quick Ratio	0.76	0.76	1.21	0.83	0.84	0.93
Current Ratio	2.57	2.57	3.66	2.57	2.85	3.10
Return on Equity (ROE)	-1.80%	-1.80%	-4.50%	-8.67%	2.67%	-2.15%
Return on Assets (ROA)	2.08%	2.08%	-0.41%	-0.78%	1.29%	-0.59%
Return on Invested Capital (ROIC)	4.04%	4.21%	-0.78%	-1.40%	1.88%	-1.07%
Return on Capital Employed (ROCE)	4.10%	4.10%	-1.20%	-1.40%	2.30%	-1.00%
Earnings Yield	-2.45%	-2.66%	35.26%	-2.26%	2.95%	-1.48%
FCF Yield	-0.23%	-0.24%	-1.00%	0.38%	-7.50%	-14.10%
Buyback Yield / Dilution	-0.02%	-0.02%	-0.02%	-0.04%	-0.05%	-12.20%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.